Division of Cardiology, Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Healthcare Analytics Unit, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Pediatr Cardiol. 2022 Mar;43(3):636-644. doi: 10.1007/s00246-021-02768-x. Epub 2021 Nov 15.
The relationship between center-specific variation in indication for pediatric heart transplantation and short-term outcomes after heart transplantation is not well described. We used merged patient- and hospital-level data from the United Network for Organ Sharing and the Pediatric Health Information Systems to analyze outcomes according to transplant indication for a cohort of children (≤ 21 years old) who underwent heart transplantation between 2004 and 2015. Outcomes included 30-day mortality, transplant hospital admission mortality, and hospital length of stay, with multivariable adjustment performed according to patient and center characteristics. The merged cohort reflected 2169 heart transplants at 20 U.S. centers. The median number of transplants annually at each center was 11.6, but ranged from 3.5 to 22.6 transplants/year. Congenital heart disease was the indication in the plurality of cases (49.2%), with cardiomyopathy (46%) and myocarditis (4.8%) accounting for the remainder. There was significant center-to-center variability in congenital heart disease as the principal indication, ranging from 15% to 66% (P < 0.0001). After adjustment, neither center volume nor proportion of indications for transplantation were associated with 30-day or transplant hospital admission mortality. In this large, merged pediatric cohort, variation was observed at center level in annual transplant volume and prevalence of indications for heart transplantation. Despite this variability, center volume and proportion of indications represented at a given center did not appear to impact short-term outcomes.
心脏移植适应证中心特异性差异与心脏移植后短期结局的关系尚未很好描述。我们使用来自器官共享联合网络和儿科健康信息系统的合并患者和医院水平数据,根据 2004 年至 2015 年间接受心脏移植的儿童(≤21 岁)的移植适应证分析结局。结局包括 30 天死亡率、移植医院入院死亡率和住院时间,根据患者和中心特征进行多变量调整。合并队列反映了 20 个美国中心的 2169 例心脏移植。每个中心每年的中位数移植例数为 11.6 例,但范围为 3.5 至 22.6 例/年。先天性心脏病是大多数情况下的适应证(49.2%),心肌病(46%)和心肌炎(4.8%)占其余部分。先天性心脏病作为主要适应证的中心间存在显著差异,范围为 15%至 66%(P<0.0001)。调整后,中心容量和移植适应证比例均与 30 天或移植医院入院死亡率无关。在这个大型的合并儿科队列中,中心层面的年度移植量和心脏移植适应证的流行率存在差异。尽管存在这种变异性,但在特定中心代表的中心容量和适应证比例似乎并未影响短期结局。